Comparing the efficacy and safety of nafamostat mesylate versus citrate for anticoagulation in continuous renal replacement therapy: a systematic review and meta-analysis
BackgroundAnticoagulation is pivotal to the successful implementation of continuous renal replacement therapy (CRRT). Systematic comparative studies between nafamostat mesylate (NM) and citrate are scarce. There is currently a lack of evidence-based support for clinical practice.ObjectiveTo systemat...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2026-07-01
|
| Serie: | Frontiers in Medicine |
| Soggetti: | |
| Accesso online: | https://www.frontiersin.org/articles/10.3389/fmed.2026.1831023/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|